Funder
National Institutes of Health
National Institute of Allergy and Infectious Diseases
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,Social Psychology
Reference27 articles.
1. Ostrowski M, Benko E, Yue FY, et al. Intensifying antiretroviral therapy with raltegravir and maraviroc during early human immunodeficiency virus (HIV) infection does not accelerate HIV reservoir reduction. Open Forum Infect Dis. 2015;2(4):ofv138.
2. Le T, Wright EJ, Smith DM, et al. Enhanced CD4 + T-cell recovery with earlier HIV-1 antiretroviral therapy. N Engl J Med. 2013;368(3):218–30.
3. Okulicz JF, Le TD, Agan BK, et al. Influence of the timing of antiretroviral therapy on the potential for normalization of immune status in human immunodeficiency virus 1-infected individuals. JAMA Intern Med. 2015;175(1):88–99.
4. Friedman SR, Downing MJ Jr, Smyrnov P, et al. Socially-integrated transdisciplinary HIV prevention. AIDS Behav. 2014;18(10):1821–34.
5. Mastro TD, Kim AA, Hallett T, et al. Estimating HIV incidence in populations using tests for recent infection: issues, challenges and the way forward. J HIV AIDS Surveill Epidemiol. 2010;2(1):1–14.